Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE

Clinical trial NCT01291667 · COMPLETED

Trial details

NCT number: NCT01291667
Sponsor: Shanghai CP Guojian Pharmaceutical Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Progress-free Survival Overall Response Rate Adverse Events

Start date: 2009-05-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.